50.88 USD
-2.53 (-4.74%)
52.4 USD
+1.52 (+2.99%)
BRKR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. While BRKR is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, BRKR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year BRKR was profitable.
In the past year BRKR had a positive cash flow from operations.
Each year in the past 5 years BRKR has been profitable.
BRKR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.37%, BRKR is in the better half of the industry, outperforming 64.91% of the companies in the same industry.
BRKR's Return On Equity of -0.97% is fine compared to the rest of the industry. BRKR outperforms 64.91% of its industry peers.
BRKR has a Return On Invested Capital of 4.01%. This is in the better half of the industry: BRKR outperforms 68.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRKR is below the industry average of 13.75%.
The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.01%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
In the last couple of years the Profit Margin of BRKR has declined.
BRKR has a better Operating Margin (8.99%) than 66.67% of its industry peers.
BRKR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 48.00%, BRKR is in line with its industry, outperforming 52.63% of the companies in the same industry.
BRKR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BRKR is destroying value.
BRKR has more shares outstanding than it did 1 year ago.
BRKR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRKR has a worse debt to assets ratio.
2.2 Solvency
BRKR has an Altman-Z score of 2.62. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score of 2.62. This is comparable to the rest of the industry: BRKR outperforms 59.65% of its industry peers.
BRKR has a Debt/Equity ratio of 0.82. This is a neutral value indicating BRKR is somewhat dependend on debt financing.
The Debt to Equity ratio of BRKR (0.82) is worse than 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.62 |
ROIC/WACC0.39
WACC10.2%
2.3 Liquidity
BRKR has a Current Ratio of 1.85. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.85, BRKR is doing worse than 61.40% of the companies in the same industry.
A Quick Ratio of 0.89 indicates that BRKR may have some problems paying its short term obligations.
BRKR's Quick ratio of 0.89 is on the low side compared to the rest of the industry. BRKR is outperformed by 84.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
The earnings per share for BRKR have decreased strongly by -18.37% in the last year.
BRKR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
The Revenue has been growing slightly by 6.10% in the past year.
BRKR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.19% yearly.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
BRKR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.58% yearly.
BRKR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.38% yearly.
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 25.44, which means the current valuation is very expensive for BRKR.
Based on the Price/Earnings ratio, BRKR is valued a bit cheaper than 78.95% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. BRKR is around the same levels.
Based on the Price/Forward Earnings ratio of 23.34, the valuation of BRKR can be described as rather expensive.
BRKR's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRKR is cheaper than 80.70% of the companies in the same industry.
BRKR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.44 | ||
| Fwd PE | 23.34 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRKR is valued cheaper than 82.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 18.76 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)2.84
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
5. Dividend
5.1 Amount
BRKR has a yearly dividend return of 0.38%, which is pretty low.
BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.09. BRKR pays more dividend than 89.47% of the companies in the same industry.
With a Dividend Yield of 0.38, BRKR pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
BRKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
The earnings of BRKR are negative and hence is the payout ratio. BRKR will probably not be able to sustain this dividend level.
BRKR's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
50.88
-2.53 (-4.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners90.2%
Inst Owner Change0.06%
Ins Owners26.95%
Ins Owner Change0.17%
Market Cap7.73B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts79.09
Price Target51.65 (1.51%)
Short Float %11.12%
Short Ratio4.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)8.84%
PT rev (3m)12.88%
EPS NQ rev (1m)-0.26%
EPS NQ rev (3m)-24.3%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-4.48%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.44 | ||
| Fwd PE | 23.34 | ||
| P/S | 2.25 | ||
| P/FCF | N/A | ||
| P/OCF | 81.98 | ||
| P/B | 3.18 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.76 |
EPS(TTM)2
EY3.93%
EPS(NY)2.18
Fwd EY4.28%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.22%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.84
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.62 |
F-Score5
WACC10.2%
ROIC/WACC0.39
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year9.99%
EBIT Next 3Y11.38%
EBIT Next 5Y10.68%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status for BRKR stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for BRKR stock?
The Price/Earnings (PE) ratio for BRUKER CORP (BRKR) is 25.44 and the Price/Book (PB) ratio is 3.18.
What is the financial health of BRUKER CORP (BRKR) stock?
The financial health rating of BRUKER CORP (BRKR) is 2 / 10.